Boulware David R, Stauffer William M, Hendel-Paterson Brett R, Rocha Jaime Luís Lopes, Seet Raymond Chee-Seong, Summer Andrea P, Nield Linda S, Supparatpinyo Khuanchai, Chaiwarith Romanee, Walker Patricia F
Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis 55455, USA.
Am J Med. 2007 Jun;120(6):545.e1-8. doi: 10.1016/j.amjmed.2006.05.072.
Strongyloidiasis infects hundreds of millions of people worldwide and is an important cause of mortality from intestinal helminth infection in developed countries. The persistence of infection, increasing international travel, lack of familiarity by health care providers, and potential for iatrogenic hyperinfection all make strongyloidiasis an important emerging infection.
Two studies were performed. A retrospective chart review of Strongyloides stercoralis cases identified through microbiology laboratory records from 1993-2002 was conducted. Subsequently, 363 resident physicians in 15 training programs worldwide were queried with a case scenario of strongyloidiasis, presenting an immigrant with wheezing and eosinophilia. The evaluation focused on resident recognition and diagnostic recommendations.
In 151 strongyloidiasis cases, stool ova and parasite sensitivity is poor (51%), and eosinophilia (>5% or >400 cells/microL) commonly present (84%). Diagnosis averaged 56 months (intra-quartile range: 4-72 months) after immigration. Presenting complaints were nonspecific, although 10% presented with wheezing. Hyperinfection occurred in 5 patients prescribed corticosteroids, with 2 deaths. Treatment errors occurred more often among providers unfamiliar with immigrant health (relative risk of error: 8.4; 95% confidence interval, 3.4-21.0; P <.001). When presented with a hypothetical case scenario, US physicians-in-training had poor recognition (9%) of the need for parasite screening and frequently advocated empiric corticosteroids (23%). International trainees had superior recognition at 56% (P <.001). Among US trainees, 41% were unable to choose any parasite causing pulmonary symptoms.
Strongyloidiasis is present in US patients. Diagnostic consideration should occur with appropriate exposure, nonspecific symptoms including wheezing, or eosinophilia (>5% relative or >400 eosinophils/microL). US residents' helminth knowledge is limited and places immigrants in iatrogenic danger. Information about Strongyloides should be included in US training and continuing medical education programs.
粪类圆线虫病感染了全球数亿人,是发达国家肠道蠕虫感染致死的重要原因。感染的持续存在、国际旅行的增加、医疗保健人员对此缺乏了解以及医源性播散性感染的可能性,都使粪类圆线虫病成为一种重要的新发感染性疾病。
进行了两项研究。对1993年至2002年通过微生物学实验室记录确定的粪类圆线虫病例进行了回顾性病历审查。随后,对全球15个培训项目中的363名住院医师进行了关于粪类圆线虫病病例情况的询问,该病例为一名有喘息和嗜酸性粒细胞增多的移民。评估重点是住院医师的识别能力和诊断建议。
在151例粪类圆线虫病病例中,粪便虫卵和寄生虫检测的敏感性较差(51%),嗜酸性粒细胞增多(>5%或>400个细胞/微升)常见(84%)。移民后平均56个月(四分位间距:4 - 72个月)确诊。就诊主诉不具特异性,尽管10%的患者有喘息症状。5例接受皮质类固醇治疗的患者发生了播散性感染,2例死亡。在不熟悉移民健康情况的医疗人员中治疗错误更常见(错误相对风险:8.4;95%置信区间,3.4 - 21.0;P <.001)。当面对一个假设的病例情况时,美国接受培训的医师对寄生虫筛查需求的识别能力较差(9%),且经常主张经验性使用皮质类固醇(23%)。国际学员的识别能力较好,为56%(P <.001)。在美国学员中,41%无法选出任何可导致肺部症状的寄生虫。
美国患者中存在粪类圆线虫病。对于有适当暴露史、包括喘息在内的非特异性症状或嗜酸性粒细胞增多(>5%或嗜酸性粒细胞>400/微升)的患者,应考虑进行诊断。美国住院医师的蠕虫知识有限,使移民处于医源性危险之中。关于粪类圆线虫的信息应纳入美国的培训和继续医学教育项目中。